Closing the Gap in First-Line Treatment of KRAS G12C–Mutated Advanced NSCLC: From Biology to Bedside Decisions and Trial-Ready Care

Improve first-line care for KRAS G12C–mutated advanced NSCLC through timely biomarker testing, personalized treatment strategy, and clinical trial referral.

ReachMD Healthcare Image
Cancellation Policy

NEW FEATURES:

Register

We're glad to see you're enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free